A Single-stage Bilayered Skin Reconstruction With Glyaderm ®
Conditions: Burns; Full Thickness Burn; Necrotizing Fascitis Interventions: Procedure: Dermal subsitute Glyaderm + skin graft; Procedure: Skin graft alone Sponsors: University Hospital, Ghent; Research Foundation Flanders Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis
Conditions: Dermatitis, Atopic Interventions: Drug: BMS-986326; Other: Placebo Sponsors: Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
A Prospective, Multicenter, Post-marketing Clinical Follow-up Research to Evaluate the Long-term Safety of Ellans é-S Dermal Filler Made of PCL Microspheres for the Correction of Moderate-to-severe Nasolabial Folds
Conditions: Moderate-to-severe Nasolabial Folds (3-4 Level of WSRS Scores) on Both Sides of the Face Interventions: Device: Ellans é-S Sponsors: AQTIS Medical B.V. Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Topical Treatment for Atopic Dermatitis
Conditions: Atopic Dermatitis Interventions: Other: Demonstration of applying triamcinolone cream; Behavioral: Mobile App Use; Other: Standard of Care Sponsors: Wake Forest University Health Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Vestibular Socket Therapy Using Acellular Dermal Matrix Versus Connective Tissue Graft
Conditions: Immediate Implant Interventions: Device: implant; Procedure: Vestibular Socket Therapy; Drug: Alloderm; Drug: Xenogenic bone membrane shield; Procedure: Connective tissue graft Sponsors: Tanta University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Adults With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
Conditions: Dermatitis Atopic Interventions: Drug: Amlitelimab; Drug: Placebo; Drug: Topical corticosteroids; Drug: Topical tacrolimus or pimecrolimus Sponsors: Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
Conditions: Moderate to Severe Atopic Dermatitis Interventions: Drug: Methotrexate; Drug: Placebo Sponsors: medac GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis
Conditions: Atopic Dermatitis Interventions: Drug: Ruxolitinib Cream; Drug: Vehicle Cream Sponsors: Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
Conditions: Atopic Dermatitis Sponsors: CorEvitas Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Impact of Covid-19 on Occupational Dermato-allergology Consultations of Health Peronnel
Conditions: Dermatoses; Health Personnel Sponsors: Centre Hospitalier Intercommunal Creteil Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Bio-Thera Solutions Announces Initiation of Phase IB / IIA Clinical Trial for BAT6026, a Monoclonal Antibody Targeting OX40, in Patients with Moderate to Severe Atopic Dermatitis
GUANGZHOU, China, Feb. 1, 2024 /PRNewswire/ -- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today announced that dosing has begun in Phase IA/IIB... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 1, 2024 Category: Pharmaceuticals Source Type: clinical trials
This Research Study Aims to Investigate the Efficacy of Using Dermabond and Dermabond Prineo for Wound Closure in Total Knee Arthroplasty, Which Had More Impact to Patient Satisfaction Evaluated by POSAS Score
Conditions: OsteoArthritis Knee Interventions: Device: Skin adhesive (Dermabond); Device: skin adhesive + polyester mesh Sponsors: Pooriwat Lertsurawat; Kittipon Naratrikun Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Soft Tissue Graft Versus Acellular Dermal Matrix in Preservation of Buccal Plate of Bone
Conditions: Comparative Study Interventions: Combination Product: Acellular Dermal Matrix Sponsors: Faculty of Dental Medicine for Girls Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Acellular Dermal Allograft for Chronic Diabetic Wounds
Conditions: Wound Heal; Diabetic Foot Ulcer Interventions: Other: decellularized dermal matrix Sponsors: University Health Network, Toronto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Pilot Study: AI Algorithm for Dermatology Referral Optimization
Conditions: Skin Diseases; Skin Condition Sponsors: AI Labs Group S.L; Osakidetza; Servicio Vasco de Salud Osakidetza, Spain; Hospital Universitario Cruces Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
